by Nassir Ghaemi | Oct 7, 2021 | Curbside Consults
Question: I would like to ask you one question regarding your differentiation between “symptomatic” drugs like monoamine-agonists or dopamine-inhibitors and second messenger modulators, the latter showing some ability to modify the disease process as such....
